These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32439068)

  • 1. Precision Therapy for Inherited Retinal Disease: At the Forefront of Genomic Medicine.
    Koulisis N; Nagiel A
    Clin Lab Med; 2020 Jun; 40(2):189-204. PubMed ID: 32439068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR genome engineering for retinal diseases.
    Kantor A; McClements ME; Peddle CF; Fry LE; Salman A; Cehajic-Kapetanovic J; Xue K; MacLaren RE
    Prog Mol Biol Transl Sci; 2021; 182():29-79. PubMed ID: 34175046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges to Gene Editing Approaches in the Retina.
    Bonillo M; Pfromm J; Fischer MD
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):275-283. PubMed ID: 35316854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo application of base and prime editing to treat inherited retinal diseases.
    Jo DH; Bae S; Kim HH; Kim JS; Kim JH
    Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy for Inherited Retinal Degeneration.
    Arbabi A; Liu A; Ameri H
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):79-97. PubMed ID: 30688548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.
    Zaneveld J; Wang F; Wang X; Chen R
    Sci China Life Sci; 2013 Feb; 56(2):125-33. PubMed ID: 23393028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
    Lin WV; Stout JT; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.
    Chien Y; Hsiao YJ; Chou SJ; Lin TY; Yarmishyn AA; Lai WY; Lee MS; Lin YY; Lin TW; Hwang DK; Lin TC; Chiou SH; Chen SJ; Yang YP
    J Nanobiotechnology; 2022 Dec; 20(1):511. PubMed ID: 36463195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR in the Retina: Evaluation of Future Potential.
    Cho GY; Justus S; Sengillo JD; Tsang SH
    Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 genome surgery for retinal diseases.
    Xu CL; Park KS; Tsang SH
    Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene editing technology: Towards precision medicine in inherited retinal diseases.
    Ballios BG; Pierce EA; Huckfeldt RM
    Semin Ophthalmol; 2021 May; 36(4):176-184. PubMed ID: 33621144
    [No Abstract]   [Full Text] [Related]  

  • 16. Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.
    Chrenek MA; Nickerson JM; Boatright JH
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):304-8. PubMed ID: 27488072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
    Hansen S; McClements ME; Corydon TJ; MacLaren RE
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases.
    Shamshad A; Kang C; Jenny LA; Persad-Paisley EM; Tsang SH
    Vision Res; 2023 Sep; 210():108258. PubMed ID: 37244011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Gene Editing in Inherited Retinal Disorders.
    Ling J; Jenny LA; Zhou A; Tsang SH
    Cold Spring Harb Perspect Med; 2023 Apr; 13(4):. PubMed ID: 36096547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.
    Wang D; Zhang F; Gao G
    Cell; 2020 Apr; 181(1):136-150. PubMed ID: 32243786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.